March 13, 2018 | Denise Heady
Fourteen years ago, neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., began to travel to underserved countries to perform brain surgeries on disadvantaged children.
Yuman Fong, M.D.: Global Physician
February 14, 2018 | Abe Rosenberg
From Cuba to Calcutta, across Asia, throughout Europe and North and South America, City of Hope's Yuman Fong, M.D's go-anywhere philosophy has taken him everywhere. Some visits last only a few hours. But each carries a specific purpose.
Heated Chemotherapy Can Tackle Tough Peritoneal Cancers
October 3, 2017 | Samantha Bonar
Cancers that affect or metastasize to the peritoneal cavity (the abdominal area that contains organs such as the stomach and liver) can be difficult to treat. Heated intraoperative peritoneal chemotherapy (HIPEC) can help.
Liver Cancer: What You Need To Know
November 1, 2016 | Abe Rosenberg
City of Hope is a leader in liver cancer detection and treatment. Here, surgeon and researcher Susanne Gray Warner, M.D. explains how to better understand how this cancer works; where it comes from; and how it is treated.
Liver cancer 2016: From immunotherapy to gene therapy and beyond
December 24, 2015 | Veronique de Turenne
By the end of 2016, treatment for liver cancer could look much different than it does now. Progress in the evolving field of immunotherapy and the emerging field of viral-based gene therapy herald a promising new era in the field of liver cancer.
Liver cancer awareness: What you should know
October 27, 2015 | Valerie Howard
Although liver cancer is considered relatively rare, striking an estimated 33,000 Americans each year - mostly men over the age of 45 - it is extremely challenging to treat if not caught early. At City of Hope, expert researchers and doctors such as Laleh Melstrom, M.D., M.S, are working tirelessly to advance liver cancer research and treatment, in order to improve early detection and survival rates.
Specific protein may be powerful indicator of liver cancer, study finds
March 8, 2015 | Darrin Joy
Liver cancer is terribly difficult to cure. Despite significant treatment advances, five-year survival rates remain at about 15 percent overall — and they rapidly approach zero when the disease is found too late.
Cancer research 2015: T cell immunotherapy, targeted drugs and more
January 1, 2015 | Tami Dennis
Every year, researchers make gains in the understanding of cancer, and physicians make gains in the treatment of cancer. As a result, every year, more cancer patients survive their disease. In 2015, cancer research will move forward in ways both high-profile and little-heralded.
Cancer 2015: Liver cancer expert offers view from the front lines
December 24, 2014 | Tami Dennis
Yuman Fong, M.D., is an internationally recognized expert in hepatobiliary cancer – that is liver cancer, pancreatic cancer, gallbladder cancer and cancer of the bile ducts. He's also renowned for his use of genetically modified viruses to combat malignant disease, is a pioneer in the operating room and the laboratory, is the author of more than 600 peer-reviewed articles and 11 textbooks, and is the chair of the Department of Surgery at City of Hope.
Made in City of Hope: Pushing the limits of liver cancer surgery (w/VIDEO)
November 6, 2014 | City of Hope
Cancer that spreads to the liver poses a significant threat to patients, and a great challenge to surgeons. The organ’s anatomical complexity and its maze of blood vessels make removal of tumors difficult, even for specialized liver cancer surgeons.